Malaria


Leading malaria researcher Professor Leann Tilley and her team have uncovered the mechanism of how frontline antimalarial drug, artemisinin, works and are now working on a promising chemotherapy-based compound to treat patients.

Bio21's Dr Duffy believes the key to combating the public health challenge of malaria is to focus on those people who are most susceptible to severe malaria – young children – and focus on those malaria strains that are most likely to cause death.

A new genetic fingerprinting technique has for the first time shown the huge genetic diversity of the malaria parasite, one of nature’s most persistent and successful human pathogens.

Research linking cancer drugs to overcoming drug-resistant malaria puts team in contention for Eureka Prize

Human red blood cells have remarkable abilities, allowing them to bend, extend and ‘squeeze’ through capillaries as they circulate through the blood stream.

Image for September: Residents of a community in the Upper East Region Ghana